๐ฌ Dr. Shuwei Zhou is a distinguished researcher specializing in imaging and nuclear medicine at Zhongda Hospital, Southeast University, China. ๐ฅ She holds a Ph.D. in Imaging and Nuclear Medicine from Southeast University and a B.A. & Masterโs from Hunan University of Chinese Medicine. ๐ Dr. Zhou has authored numerous high-impact SCI publications ๐ focusing on HCC, LI-RADS, MRI diagnostics, and treatment response. Her contributions include 4 national research projects and 2 patents. ๐ As a leading expert in radiology and medical imaging, her work advances diagnostic accuracy and patient care in oncology and musculoskeletal disorders. โ๏ธโจ
Publication Profile
Scopus
Education
Ms. Shuwei Zhou ๐ has showcased outstanding academic excellence, earning a Ph.D. in Imaging and Nuclear Medicine from the School of Medicine at Southeast University ๐ฅ. Her strong foundation in the field began at Hunan University of Chinese Medicine, where she completed her B.A. and Masterโs degree, ranking 1st out of 159 students ๐. With expertise in molecular and functional imaging, interventional radiology, and pathology ๐ฌ, she has developed a deep understanding of advanced medical diagnostics. Her dedication to research and innovation continues to shape the future of nuclear medicine and imaging technology. ๐
Experienceย
Ms. Shuwei Zhou ๐ฌ has made significant research contributions, publishing in esteemed journals like the American Journal of Roentgenology, Abdominal Radiology, and Frontiers in Immunology ๐. As the first author, she has led groundbreaking studies on MRI contrast agents, diagnostic performance, and treatment response in hepatocellular carcinoma (HCC) ๐ฅ. Her interdisciplinary expertise extends to osteoporosis prediction, the role of gut microbiota in inflammatory bowel disease, and dual-energy CT for bone mineral density ๐ฆด. Through her innovative research, she continues to advance medical imaging and diagnostic precision, making a lasting impact on the field of nuclear medicine. ๐
Awards
Ms. Shuwei Zhou ๐ is a distinguished researcher whose impressive portfolio includes first-author contributions in high-impact journals, leadership in scientific projects, and remarkable interdisciplinary expertise ๐ฌ. Her groundbreaking work in imaging and nuclear medicine, particularly in hepatocellular carcinoma research and diagnostic imaging techniques ๐ฅ, has significantly advanced the field. With a strong commitment to innovation and precision in medical diagnostics, she continues to push the boundaries of research. Her achievements make her a highly deserving candidate for the Best Researcher Award ๐, recognizing her invaluable contributions to the future of medical imaging and nuclear medicine. ๐
Research Focus
Shuwei Zhouโs research primarily focuses on medical imaging ๐ฅ๐ก and oncology, with a particular emphasis on hepatocellular carcinoma (HCC) ๐จ๐งฌ and non-radiation treatment response assessment. She is actively involved in the development of diagnostic algorithms ๐๐, such as the LI-RADS Nonradiation Treatment Response Algorithm, and predictive models like the TRACE Model, which help evaluate the effectiveness of transarterial chemoembolization (TACE) ๐โ๏ธ in patients with unresectable liver cancer. Her contributions aim to enhance precision medicine ๐ฏ and optimize clinical decision-making for better patient outcomes.
Publication Top Notes
LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma